Marshall Wace
NKGN

Marshall Wace’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History

Marshall Wace’s Portfolio NKGN Stock Details NKGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-589,724
Closed -$5.87M – 3308
2022
Q4 		$5.87M Hold
589,724
– – 0.02% 1098
2022
Q3 		$5.75M Buy
589,724
+535,635
+990% +$5.23M 0.01% 1273
2022
Q2 		$525K Hold
54,089
– – ﹤0.01% 2769
2022
Q1 		$523K Hold
54,089
– – ﹤0.01% 2754
2021
Q4 		$523K Buy
54,089
+3,552
+7% +$34.6K ﹤0.01% 2772
2021
Q3 		$490K Buy
+50,537
New +$493K ﹤0.01% 2392

Other funds holding NKGN

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $574M AUM 6.51% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.83B AUM 190.64% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.36B AUM 24.94% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $678M AUM 0.91% 1-Year Est. Return
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return